Hlib Chabaniuk

Injective holds $6.82 support amid weak momentum and continued downward price move

Injective holds $6.82 support amid weak momentum and continued downward price move
Injective drops 7.92% to $7.18 today

Injective (INJ) is trading at $7.18, down 7.92% over the last 24 hours. The price is currently below key short- and medium-term moving averages, while holding above longer-term trend indicators.

INJ price prediction
24H -2.1%
$6.53
48H -2.4%
$6.51
7D -19.49%
$5.37
1M -12.74%
$5.82
3M -67.02%
$2.2
6M -79.01%
$1.4
12M 16.34%
$7.76
Current price: $6.67 -0.46 6.48%
Real-time Data 13:30
Daily range 6.6 Arrow from to Icon 6.99
Weekly range 6.56 Arrow from to Icon 8.44
Loading...

Highlights

  • INJ/USD is trading below key short- and medium-term moving averages, indicating persistent downside momentum.
  • Momentum indicators, including MACD and ADX, confirm a broadly bearish bias, with sellers dominating intraday action.
  • INJ/USD is expected to fluctuate between $6.82 and $7.41 in the next two to three days, with a higher probability of further downside.

Momentum weakens as sellers dominate below resistance

On the hourly chart, INJ/USD remains below the MA-20 at $7.55 and MA-50 at $7.74, while price action is sustained above the MA-200 at $5.47. The Ichimoku Kijun level at $7.56 serves as immediate resistance. Momentum indicators show broad weakness: both MACD and ADX signal selling conditions, while RSI stands at 38.13 and CCI highlights additional downside risk. Bull/Bear Power also indicates clear seller dominance intraday, although the Stochastic RSI and Awesome Oscillator are neutral, pointing to mixed short-term oscillators.

Injective asset chart
Injective price dynamics. Source: TradingView.

Volatility persists amid downside risk and resistance test

Over the next two to three trading days, INJ is expected to fluctuate between $6.82 and $7.41, reflecting continued volatility. The probability of further gains is very low, while substantial downside risk persists within this volatility band. A bullish scenario would require a decisive move above the $7.56 resistance, whereas a break below the $6.82 support could open the way for additional losses.

Viktoras Karapetjanc, expert at Traders Union, sees the short-term outlook for Injective as fragile but not without hope. The analyst notes that all key momentum signals are weak, and sellers hold the advantage while the price fails to clear resistance at $7.56. However, he believes that the broader trend remains constructive as long as the price stays above the long-term average. Karapetjanc maintains a positive long-term view, seeing current volatility as a chance for renewed upside if crucial levels are reclaimed. "If INJ can push decisively above $7.56, I see momentum shifting back in favor of buyers."

Earlier, analysts noted that Injective was exhibiting persistent short- and medium-term weakness despite positive ecosystem developments. The latest technical signals reinforce this view, suggesting traders should monitor the $7.56 resistance and $6.82 support as key levels for any potential breakouts or downside extension.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.